🚀 VC round data is live in beta, check it out!
- Public Comps
- Health Catalyst
Health Catalyst Valuation Multiples
Discover revenue and EBITDA valuation multiples for Health Catalyst and similar public comparables like Senzime, Nightingale Health, Revium Recovery, Research Solutions and more.
Health Catalyst Overview
About Health Catalyst
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Founded
2011
HQ

Employees
1.5K
Website
Financials (LTM)
EV
$172M
Health Catalyst Financials
Health Catalyst reported last 12-month revenue of $302M and EBITDA of $40M.
In the same LTM period, Health Catalyst generated $150M in gross profit, $40M in EBITDA, and $12M in net income.
Revenue (LTM)
Health Catalyst P&L
In the most recent fiscal year, Health Catalyst reported revenue of $311M and EBITDA of $41M.
Health Catalyst expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $302M | XXX | $311M | XXX | XXX | XXX |
| Gross Profit | $150M | XXX | $152M | XXX | XXX | XXX |
| Gross Margin | 50% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | $40M | XXX | $41M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| EBIT Margin | (41%) | XXX | (14%) | XXX | XXX | XXX |
| Net Profit | $12M | XXX | $13M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | — | — | $102M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Health Catalyst Stock Performance
Health Catalyst has current market cap of $96M, and enterprise value of $172M.
Market Cap Evolution
Health Catalyst's stock price is $1.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $172M | $96M | 3.2% | XXX | XXX | XXX | $0.18 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHealth Catalyst Valuation Multiples
Health Catalyst trades at 0.6x EV/Revenue multiple, and 4.3x EV/EBITDA.
EV / Revenue (LTM)
Health Catalyst Financial Valuation Multiples
As of April 18, 2026, Health Catalyst has market cap of $96M and EV of $172M.
Equity research analysts estimate Health Catalyst's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Health Catalyst has a P/E ratio of 7.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $96M | XXX | $96M | XXX | XXX | XXX |
| EV (current) | $172M | XXX | $172M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 4.3x | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBIT | (1.4x) | XXX | (4.0x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| P/E | 7.9x | XXX | 7.4x | XXX | XXX | XXX |
| EV/FCF | (10.6x) | XXX | (8.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Health Catalyst Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Health Catalyst Margins & Growth Rates
Health Catalyst's revenue in the last 12 month declined by (7%).
Health Catalyst's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Health Catalyst's rule of 40 is 3% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Health Catalyst's rule of X is (12%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Health Catalyst Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (7%) | XXX | (10%) | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Growth | (10%) | XXX | (15%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 3% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (12%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 15% | XXX | 16% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 14% | XXX | 14% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 15% | XXX | 16% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 62% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Health Catalyst Public Comps
See public comps and valuation multiples for other Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Health Catalyst | XXX | XXX | XXX | XXX | XXX | XXX |
| Senzime | XXX | XXX | XXX | XXX | XXX | XXX |
| Nightingale Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Revium Recovery | XXX | XXX | XXX | XXX | XXX | XXX |
| Research Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| Champions Oncology | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Health Catalyst M&A Activity
Health Catalyst acquired XXX companies to date.
Last acquisition by Health Catalyst was on XXXXXXXX, XXXXX. Health Catalyst acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Health Catalyst
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHealth Catalyst Investment Activity
Health Catalyst invested in XXX companies to date.
Health Catalyst made its latest investment on XXXXXXXX, XXXXX. Health Catalyst invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Health Catalyst
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Health Catalyst
| When was Health Catalyst founded? | Health Catalyst was founded in 2011. |
| Where is Health Catalyst headquartered? | Health Catalyst is headquartered in United States. |
| How many employees does Health Catalyst have? | As of today, Health Catalyst has over 1K employees. |
| Who is the CEO of Health Catalyst? | Health Catalyst's CEO is Benjamin Albert. |
| Is Health Catalyst publicly listed? | Yes, Health Catalyst is a public company listed on Nasdaq. |
| What is the stock symbol of Health Catalyst? | Health Catalyst trades under HCAT ticker. |
| When did Health Catalyst go public? | Health Catalyst went public in 2019. |
| Who are competitors of Health Catalyst? | Health Catalyst main competitors are Senzime, Nightingale Health, Revium Recovery, Research Solutions. |
| What is the current market cap of Health Catalyst? | Health Catalyst's current market cap is $96M. |
| What is the current revenue of Health Catalyst? | Health Catalyst's last 12 months revenue is $302M. |
| What is the current revenue growth of Health Catalyst? | Health Catalyst revenue growth (NTM/LTM) is (7%). |
| What is the current EV/Revenue multiple of Health Catalyst? | Current revenue multiple of Health Catalyst is 0.6x. |
| Is Health Catalyst profitable? | Yes, Health Catalyst is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Health Catalyst? | Health Catalyst's last 12 months EBITDA is $40M. |
| What is Health Catalyst's EBITDA margin? | Health Catalyst's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Health Catalyst? | Current EBITDA multiple of Health Catalyst is 4.3x. |
| What is the current FCF of Health Catalyst? | Health Catalyst's last 12 months FCF is ($16M). |
| What is Health Catalyst's FCF margin? | Health Catalyst's last 12 months FCF margin is (5%). |
| What is the current EV/FCF multiple of Health Catalyst? | Current FCF multiple of Health Catalyst is (10.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.